Triple P for Parents of Children With a Diagnosis of Cancer
1 other identifier
interventional
4
1 country
1
Brief Summary
The purpose of the study is to assess the characteristics of parents who enroll in parenting interventions and to assess the utility and efficacy of a self-directed Triple-P intervention for parents of children with a diagnosis of cancer. The study aims to recruit parent(s) or primary caregiver of children with a diagnosis of cancer.Participants will be parents of children aged between 3-10 years who have had a diagnosis of cancer for 6 months or more. Recruitment will take place nationally via cancer voluntary groups/charities and other relevant organisations. The project will be advertised through these organisations and their various media outlets such as newsletters and social media pages (e.g. Facebook). All data collection will take place online. Following completion of the initial survey, parents will have the option to opt in to a case series whereby 10 parents will have the opportunity to receive the Triple P Every parents self- directed workbook to complete over 10 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1 cancer
Started Jan 2016
Shorter than P25 for phase_1 cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 23, 2015
CompletedStudy Start
First participant enrolled
January 1, 2016
CompletedFirst Posted
Study publicly available on registry
January 6, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2016
CompletedOctober 25, 2016
October 1, 2016
7 months
September 23, 2015
October 24, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Quality of life as measured by Royal Marsden Hospital Paediatric Oncology Quality of Life Questionnaire (RMH-PQLQ)
Improving quality of life
Week 1, Week 5, Week 10 and 1 month following completion.
Secondary Outcomes (4)
Change in behavioural and emotional difficulties as measured by Royal Marsden Hospital Paediatric Oncology Quality of Life Inventory (RMH-PQLQ) Life Questionnaire
Week1, (baseline between 1-3 weeks), week 5, Week 10 and 1 month following completion
Change in parenting style as measured by Parenting Scale (PS)
Week 1, Week 5, Week 10 and 1 month following completion.
Change in parental confidence as measured by Parenting Sense of Competence Questionnaire (PSOC)
Week 1, Week 5, Week 10 and 1 month following completion.
Change in parents thoughts and feelings related to parenting a child with cancer as measured by Parent Experience of Childhood Illness questionnaire
Week 1, Week 5, Week 10 and 1 month following completion.
Study Arms (1)
Self- Direced Triple P
EXPERIMENTALSelf-directed Triple P workbook to be completed over 10 weeks. Over the course of the workbook parents will think about the changes they would like to make to their child's behaviour. They are taught strategies to enhance their relationship with their child, and promote desirable behaviours. They learn about options for managing problem behaviours and have the opportunity to decide if they would like to use any of these approaches with their child in a clear and consistent way. Parents have practice period to use the approaches they have learnt in weeks 1-3. By the end of week 6 they will have had practice in using their chosen positive parenting approaches, learnt to set goals and monitor their own behaviour when using these strategies. The final weeks aim to help parents identify times when the strategies may not be working and provide survival tips on what to do at these times.
Interventions
10 Week Triple P Self directed workbook
Eligibility Criteria
You may qualify if:
- Participant is willing and able to give informed consent for participation in the trial.
- Parent of a child with a diagnosis of cancer
- Child has had cancer diagnosis for 6 months or more
- Parent of a child aged between 3 and 10 years old
- Parent can read unsupported
- Parent and Child do not have a mental health diagnosis
You may not qualify if:
- Children between the ages of 0 to 2 years and 11 months and 11 years upwards
- Children or parent has a mental health diagnosis
- Parent unable to read without support or assistance
- Parents of child who has been diagnosed with cancer for less than 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Manchesterlead
- Royal Children's Hospitalcollaborator
Study Sites (1)
The University of Manchester
Manchester, United Kingdom
MeSH Terms
Conditions
Interventions
Study Officials
- PRINCIPAL INVESTIGATOR
Katie Swift, BSc
The University of Manchester
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Investigaor
Study Record Dates
First Submitted
September 23, 2015
First Posted
January 6, 2016
Study Start
January 1, 2016
Primary Completion
August 1, 2016
Study Completion
August 1, 2016
Last Updated
October 25, 2016
Record last verified: 2016-10